Lee Hambright

Stock Analyst at Bernstein

(3.42)
# 978
Out of 5,042 analysts
27
Total ratings
78.95%
Success rate
11.18%
Average return

Stocks Rated by Lee Hambright

Johnson & Johnson
Oct 6, 2025
Maintains: Market Perform
Price Target: $172$193
Current: $190.40
Upside: +1.37%
Medtronic
Aug 20, 2025
Maintains: Outperform
Price Target: $97$98
Current: $93.67
Upside: +4.62%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $138$144
Current: $126.85
Upside: +13.52%
Insulet
Nov 6, 2024
Initiates: Outperform
Price Target: $300
Current: $320.91
Upside: -6.52%
Tandem Diabetes Care
Nov 6, 2024
Initiates: Outperform
Price Target: $42
Current: $14.95
Upside: +180.94%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $82$86
Current: $70.33
Upside: +22.28%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $92$100
Current: $101.11
Upside: -1.10%
Intuitive Surgical
May 31, 2023
Maintains: Outperform
Price Target: $350$365
Current: $546.51
Upside: -33.21%
Zimmer Biomet Holdings
May 3, 2023
Maintains: Market Perform
Price Target: $136$152
Current: $103.03
Upside: +47.53%
Stryker
Mar 16, 2022
Upgrades: Outperform
Price Target: $288$295
Current: $381.79
Upside: -22.73%
Upgrades: Outperform
Price Target: $132$135
Current: $76.10
Upside: +77.40%